| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$32.00
Est. +105%
|
$15.64 | $18.91 |
Pending
|
$16.95
+8.4%
|
| Dec 08, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$138.00
Est. +46%
|
$94.30 | $103.00 |
Pending
|
$86.21
-8.6%
|
| Oct 30, 2025 |
Arvinas Inc
ARVN
|
BUY |
$14.00
Est. +46%
|
$9.59 | $16.14 |
Target Met
|
$7.58
-21.0%
|
| Oct 22, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$75.00
Est. +29%
|
$58.32 | $103.00 |
Target Met
|
$86.21
+47.8%
|
| Oct 10, 2025 |
Perspective Therapeutics Inc
CATX
|
BUY |
$14.00
Est. +233%
|
$4.20 | $6.16 |
Pending
|
$2.95
-29.8%
|
| Sep 09, 2025 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$87.00
Est. +94%
|
$44.93 | $105.00 |
Target Met
|
$59.77
+33.0%
|
| Jun 26, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$59.00
Est. +27%
|
$46.47 | $103.00 |
Target Met
|
$86.21
+85.5%
|
| May 02, 2025 |
Arvinas Inc
ARVN
|
BUY |
$16.00
Est. +107%
|
$7.72 | $16.14 |
Bullseye Hit (±1%)
|
$7.58
-1.8%
|
| Dec 10, 2024 |
Arvinas Inc
ARVN
|
BUY |
$69.00
Est. +181%
|
$24.59 | $25.75 |
Miss
|
$7.58
-69.2%
|